"That's not science. That's ideology." -- Gregory Poland, MD, president of the Atria Health and Research Institute in New York City, discussing the CDC's plan to look for an association between vaccines and autism, despite decades of data demonstrating the two aren't linked.
"The 'let 'er rip' strategy was disastrous for SARS-CoV-2, and it will be even worse for highly-pathogenic avian influenza." -- James Lawler, MD, MPH, of the University of Nebraska Medical Center's Global Center for Health Security in Omaha, reacting to HHS Secretary Robert F. Kennedy Jr. downplaying H5N1 bird flu concerns.
"This administration does not value the need for scientific analysis to make the best and most appropriate decisions for public health issues." -- Tina Tan, MD, president of the Infectious Diseases Society of America, discussing FDA's decision to bypass its vaccine advisory committee for the fall flu vaccine strain.
"Almost certainly we will see a reversal in the trends of progress that we've made in reducing new HIV infections." -- Colleen Kelley, MD, MPH, of Emory University in Atlanta, commenting on the Trump administration's possible plan to close the CDC's Division of HIV Prevention.
"We can either get people vaccinated, or measles is going to run rampant for a while." -- Katherine Wells, MPH, of Lubbock Public Health in Texas, discussing the current measles outbreak.
"We didn't just sit on our laurels, and you're continuing that." -- MedPage Today founder Robert Stern, reflecting on the early days of the publication on its 20th anniversary.
"We cannot exclude that different doses or daily dosing would be effective." -- Matthias Liechti, MD, of University Hospital Basel in Switzerland, discussing a small trial of a low-dose psychedelic drug for attention deficit-hyperactivity disorder (ADHD) symptoms.
"Cutting health research in rural states means cutting off new innovations that can improve health outcomes and quality of life." -- Sophia Newcomer, PhD, MPH, of the University of Montana School of Public and Community Health Sciences, after NIH grant funding was pulled from her vaccine research.
"This is a new phenomenon." -- Mahyar Etminan, PharmD, MSc, of the University of British Columbia in Vancouver, discussing a preprint paper about semaglutide (Ozempic, Wegovy) and hair loss.
"Anyone who received an inactivated vaccine between 1963 and 1967 is recommended to receive a dose of the current MMR [measles, mumps, and rubella] vaccine." -- Andrew Handel, MD, of Stony Brook Medicine in New York, on whether some adults need a measles booster.
"Millions of dollars are being spent at a relatively small marginal benefit." -- David Klebonis, of the Palm Beach Accountable Care Organization in Florida, on the costs of some skin substitutes for treating chronic wounds.
"Our findings emphasize the importance of viewing sleep health both holistically and longitudinally." -- Yue Leng, PhD, of the University of California San Francisco, on sleep pattern changes and dementia risk in elderly women.